Sign in

CIK 0001618835

  • Non-accelerated filer
  • Smaller reporting company

Evofem Biosciences, Inc.

Sign in to watch
Ticker
EVFM
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208527075
Phone
+1 858-550-1900
Business address
12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
Former names
Neothetics, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2015-09-18 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise +1,000 $1.34 $1K 11,848
2015-09-18 Kemmerer Christopher VP, Pharma Dev & Manufacturing Sale −1,000 $12.20 $12K 10,848
2015-09-18 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise · Stock Option (Right to Buy) −1,000 50,182
2015-08-07 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise +1,000 $1.34 $1K 11,848
2015-08-07 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise · Stock Option (Right to Buy) −1,000 51,182
2015-08-07 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise +1,000 $1.22 $1K 11,848
2015-08-07 Kemmerer Christopher VP, Pharma Dev & Manufacturing Sale −1,000 $12.88 $13K 10,848
2015-08-07 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise · Stock Option (Right to Buy) −1,000 1,710
2015-06-12 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise +10,848 $1.22 $13K 10,848
2015-06-12 Kemmerer Christopher VP, Pharma Dev & Manufacturing Option exercise · Common Stock (Right to Buy) −10,848 0
2015-02-10 Kemmerer Christopher VP, Pharma Dev & Manufacturing Grant or award · Stock Option (Right to Buy) +42,350 42,350

Page 1 of 1 · 11 trades